Last reviewed · How we verify
Neonatal conjunctivitis
Approved treatments
- Claforan · Sterimax
- E-Mycin · Generic (originally Abbott/Lilly)
- Aureomycin
- Benzamycin · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Neonatal conjunctivitis patent landscape — cliff calendar, originator estates, attackable patents
- Neonatal conjunctivitis treatment landscape brief
- Neonatal conjunctivitis treatment updates RSS
Frequently asked questions about Neonatal conjunctivitis
What drugs treat Neonatal conjunctivitis?
Tracked treatments include Claforan, E-Mycin, Aureomycin, Benzamycin.
What is the treatment for Neonatal conjunctivitis?
Standard treatment for Neonatal conjunctivitis includes Claforan, E-Mycin, Aureomycin, Benzamycin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Neonatal conjunctivitis patent cliff · Neonatal conjunctivitis CI report
- Treatment: Claforan · Sterimax
- Treatment: E-Mycin · Generic (originally Abbott/Lilly)
- Treatment: Aureomycin
- Treatment: Benzamycin · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing